United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 10-Q
| x |
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||
|
|
|
| ||
|
|
|
For the Quarterly Period Ended March 31, 2003 | ||
|
|
|
| ||
| o |
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||
|
|
|
| ||
|
|
|
For the Period from: ______________ to ______________ | ||
|
|
|
| ||
| Commission file number 0-22554 | ||||
|
|
|
| ||
| OPINION RESEARCH CORPORATION | ||||
| | ||||
| (Exact name of registrant as specified in its charter) | ||||
|
| ||||
| Delaware |
|
22-3118960 | ||
| |
|
| ||
| (State of incorporation) |
|
(I.R.S. Employer Identification No.) | ||
|
|
|
| ||
| 23 Orchard Road |
|
| ||
| Skillman, NJ |
|
08558 | ||
| |
|
| ||
| (Address of principal executive offices) |
|
(Zip Code) | ||
|
|
|
| ||
| 908-281-5100 | ||||
| | ||||
| (Registrants telephone number, including area code) | ||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
| Yes x |
No o |
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).
| Yes o |
No x |
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practical date.
Common Stock, $0.01 Par Value 6,042,852 shares as of March 31, 2003
Opinion Research Corporation and Subsidiaries
|
|
|
|
Page |
|
|
|
|
|
| Part I. |
|
3 | |
|
|
|
|
|
| Item 1. |
|
3 | |
|
|
|
|
|
|
|
Consolidated balance sheets March 31, 2003 and December 31, 2002 |
|
3 |
|
|
|
|
|
|
|
Consolidated statements of income - Three months ended March 31, 2003 and 2002 |
|
4 |
|
|
|
|
|
|
|
Consolidated statements of cash flows - Three months ended March 31, 2003 and 2002 |
|
5 |
|
|
|
|
|
|
|
|
6 | |
|
|
|
|
|
| Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations |
|
11 |
|
|
|
|
|
| Item 3. |
|
13 | |
|
|
|
|
|
| Item 4. |
|
13 | |
|
|
|
|
|
| Part II. |
|
14 | |
|
|
|
|
|
| Item 1. |
|
14 | |
|
|
|
|
|
| Item 2. |
|
14 | |
|
|
|
|
|
| Item 3. |
|
14 | |
|
|
|
|
|
| Item 4. |
|
14 | |
|
|
|
|
|
| Item 5. |
|
14 | |
|
|
|
|
|
| Item 6. |
|
14 | |
|
|
|
|
|
|
|
15 | ||
|
|
|
| |
|
|
16 | ||
2
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except share amounts)
(Unaudited)
|
|
|
March 31, |
|
December 31, |
| ||
|
|
|
|
|
|
|
|
|
| Assets |
|
|
|
|
|
|
|
| Current Assets: |
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
2,044 |
|
$ |
2,549 |
|
| Accounts receivable: |
|
|
|
|
|
|
|
| Billed |
|
|
20,017 |
|
|
21,936 |
|
| Unbilled services |
|
|
14,179 |
|
|
13,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,196 |
|
|
35,416 |
|
| Less: allowance for doubtful accounts |
|
|
344 |
|
|
348 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,852 |
|
|
35,068 |
|
| Prepaid and other current assets |
|
|
3,192 |
|
|
3,151 |
|
|
|
|
|
|
|
|
|
|
| Total current assets |
|
|
39,088 |
|
|
40,768 |
|
| Property and equipment, net |
|
|
8,592 |
|
|
8,549 |
|
| Intangibles, net |
|
|
1,083 |
|
|
1,230 |
|
| Goodwill |
|
|
48,490 |
|
|
48,577 |
|
| Other assets |
|
|
3,679 |
|
|
3,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
100,932 |
|
$ |
102,436 |
|
|
|
|
|
|
|
|
|
|
| Liabilities and Stockholders' Equity |
|
|
|
|
|
|
|
| Current Liabilities: |
|
|
|
|
|
|
|
| Accounts payable |
|
$ |
5,586 |
|
$ |
5,501 |
|
| Accrued expenses |
|
|
10,572 |
|
|
11,490 |
|
| Deferred revenues |
|
|
1,857 |
|
|
2,090 |
|
| Short-term borrowings |
|
|
6,625 |
|
|
6,000 |
|
| Other current liabilities |
|
|
1,388 |
|
|
954 |
|
|
|
|
|
|
|
|
|
|
| Total current liabilities |
|
|
26,028 |
|
|
26,035 |
|
| Long-term debt |
|
|
38,435 |
|
|
40,866 |
|
| Other liabilities |
|
|
1,137 |
|
|
720 |
|
| Redeemable Equity: |
|
|
|
|
|
|
|
| Preferred stock: |
|
|
|
|
|
|
|
| Series B - 10 shares designated, issued and outstanding, liquidation value of $10 per share |
|
|
|
|
|
|
|
| Series C - 588,229 shares designated, none issued or outstanding |
|
|
|
|
|
|
|
| Common stock, 1,176,458 shares issued and outstanding |
|
|
8,900 |
|
|
8,900 |
|
| Stockholders' Equity: |
|
|
|
|
|
|
|
| Preferred stock, $.01 par value, 1,000,000 shares authorized: |
|
|
|
|
|
|
|
| Series A - 10,000 shares designated, none issued or outstanding |
|
|
|
|
|
|
|
| Common stock, $.01 par value, 20,000,000 shares authorized, 4,915,216 shares issued and 4,866,394 outstanding in 2003, and 4,879,813 shares issued and 4,830,991 outstanding in 2002 |
|
|
49 |
|
|
49 |
|
| Additional paid-in capital |
|
|
19,448 |
|
|
19,302 |
|
| Retained earnings |
|
|
7,671 |
|
|
6,938 |
|
| Treasury stock, at cost, 48,822 shares in 2003 and 2002 |
|
|
(261 |
) |
|
(261 |
) |
| Accumulated other comprehensive loss |
|
|
(475 |
) |
|
(113 |
) |
|
|
|
|
|
|
|
|
|
| Total stockholders' equity |
|
|
26,432 |
|
|
25,915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
100,932 |
|
$ |
102,436 |
|
|
|
|
|
|
|
|
|
|
See notes to financial statements
3
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Income
(in thousands, except share and per share amounts)
(Unaudited)
|
|
|
Three Months Ended |
| ||||
|
|
|
|
| ||||
|
|
|
2003 |
|
2002 |
| ||
|
|
|
|
|
|
|
|
|
| Revenues |
|
$ |
43,164 |
|
$ |
42,451 |
|
| Cost of revenues (exclusive of depreciation) |
|
|
29,806 |
|
|
29,144 |
|
|
|
|
|
|
|
|
|
|
| Gross profit |
|
|
13,358 |
|
|
13,307 |
|
| Selling, general and administrative expenses |
|
|
9,974 |
|
|
9,658 |
|
| Depreciation and amortization |
|
|
946 |
|
|
1,149 |
|
|
|
|
|
|
|
|
|
|
| Operating income |
|
|
2,438 |
|
|
2,500 |
|
| Interest and other non-operating expenses, net |
|
|
1,173 |
|
|
1,185 |
|
|
|
|
|
|
|
|
|
|
| Income before provision for income taxes and cumulative effect of accounting change |
|
|
1,265 |
|
|
1,315 |
|
| Provision for income taxes |
|
|
532 |
|
|
526 |
|
|
|
|
|
|
|
|
|
|
| Income before cumulative effect of accounting change |
|
|
733 |
|
|
789 |
|
| Cumulative effect of accounting change, net of tax benefit of $0 |
|
|
|
|
|
(292 |
) |
|
|
|
|
|
|
|
|
|
| Net income |
|
$ |
733 |
|
$ |
497 |
|
|
|
|
|
|
|
|
|
|
| Basic earnings per share: |
|
|
|
|
|
|
|
| Income before cumulative effect of accounting change |
|
$ |
0.12 |
|
$ |
0.13 |
|
| Cumulative effect of accouting change |
|
|
|
|
|
(0.05 |
) |
|
|
|
|
|
|
|
|
|
| Net income |
|
$ |
0.12 |
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
| Diluted earnings per share: |
|
|
|
|
|
|
|
| Income before cumulative effect of accounting change |
|
$ |
0.12 |
|
$ |
0.13 |
|
| Cumulative effect of accouting change |
|
|
|
|
|
(0.05 |
) |
|
|
|
|
|
|
|
|
|
| Net income |
|
$ |
0.12 |
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding: |
|
|
|
|
|
|
|
| Basic |
|
|
6,042,809 |
|
|
5,896,239 |
|
| Diluted |
|
|
6,068,124 |
|
|
6,004,265 |
|
See notes to financial statements
4
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
|
|
|
Three Months Ended |
| ||||
|
|
|
|
| ||||
|
|
|
2003 |
|
2002 |
| ||
|
|
|
|
|
|
|
|
|
| Cash flows from operating activities |
|
|
|
|
|
|
|
| Net income |
|
$ |
733 |
|
$ |
497 |
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
| Depreciation and amortization |
|
|
946 |
|
|
1,149 |
|
| Cumulative effect of accounting change |
|
|
|
|
|
292 |
|
| Non-cash interest expense |
|
|
244 |
|
|
168 |
|
| Change in: |
|
|
|
|
|
|
|
| Accounts receivable |
|
|
985 |
|
|
(309 |
) |
| Other assets |
|
|
(724 |
) |
|
(1,057 |
) |
| Accounts payable and accrued expenses |
|
|
(787 |
) |
|
(58 |
) |
| Deferred revenues |
|
|
(193 |
) |
|
(84 |
) |
| Other liabilities |
|
|
680 |
|
|
(671 |
) |
|
|
|
|
|
|
|
|
|
| Net cash provided by (used in) operating activities |
|
|
1,884 |
|
|
(73 |
) |
|
|
|
|
|
|
|
|
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
| Payments for acquisitions |
|
|
|
|
|
(46 |
) |
| Capital expenditures |
|
|
(643 |
) |
|
(548 |
) |
|
|
|
|
|
|
|
|
|
| Net cash used in investing activities |
|
|
(643 |
) |
|
(594 |
) |
|
|
|
|
|
|
|
|
|
| Cash flows from financing activities: |
|
||||||